AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.750
+0.110 (2.37%)
May 15, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $170.98 million as of May 15, 2026. Its market cap has increased by 361.42% in one year.
Market Cap
170.98M
Enterprise Value
81.73M
1-Year Change
361.42%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $170.98M, a decrease of -39.17%. That is a compound annual growth rate of -11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 161.78M | 370.35% |
| Dec 31, 2025 | 34.40M | -16.47% |
| Dec 31, 2024 | 41.18M | -93.24% |
| Dec 29, 2023 | 609.28M | 229.50% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 173.85M |
| Heron Therapeutics | 172.70M |
| Acumen Pharmaceuticals | 172.62M |
| Immunic | 172.38M |
| Black Diamond Therapeutics | 163.88M |
| Equillium | 163.76M |
| Polaryx Therapeutics | 161.44M |
| Protalix BioTherapeutics | 161.14M |